Ocular Therapeutix Announces Organizational Changes To Support Development For Retinal Diseases
June 13, 2022
BEDFORD, Mass. – Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced senior leadership changes to strengthen the Company’s alignment around the development of its late-stage ophthalmology product portfolio.
Read the source article at Stock Market Quotes and News
2022-06-09 13:07:24
